SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U102. A total of 55 filers reported holding SYNTHETIC BIOLOGICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,866,000 | -47.2% | 2,446,524 | +19.2% | 0.00% | -100.0% |
| Q3 2016 | $3,531,000 | -0.3% | 2,053,133 | +4.3% | 0.00% | 0.0% |
| Q2 2016 | $3,542,000 | +944.8% | 1,967,983 | +1271.8% | 0.00% | – |
| Q1 2016 | $339,000 | -3.7% | 143,462 | -6.6% | 0.00% | – |
| Q4 2015 | $352,000 | +7.0% | 153,604 | +6.0% | 0.00% | – |
| Q3 2015 | $329,000 | -15.2% | 144,873 | +6.5% | 0.00% | – |
| Q2 2015 | $388,000 | +14.1% | 135,980 | -12.4% | 0.00% | – |
| Q1 2015 | $340,000 | +40.5% | 155,141 | -6.3% | 0.00% | – |
| Q4 2014 | $242,000 | +9.0% | 165,653 | +33.1% | 0.00% | – |
| Q3 2014 | $222,000 | +20.0% | 124,478 | +16.0% | 0.00% | – |
| Q2 2014 | $185,000 | -31.0% | 107,349 | +2.9% | 0.00% | – |
| Q1 2014 | $268,000 | +165.3% | 104,285 | +58.0% | 0.00% | – |
| Q4 2013 | $101,000 | -4.7% | 66,013 | +4.4% | 0.00% | – |
| Q3 2013 | $106,000 | +6.0% | 63,253 | +8.5% | 0.00% | – |
| Q2 2013 | $100,000 | – | 58,285 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,034,949 | $1,553,000 | 2.72% |
| Third Security, LLC | 13,238,268 | $10,095,000 | 0.54% |
| MSD Partners, L.P. | 4,118,402 | $3,141,000 | 0.16% |
| SABBY MANAGEMENT, LLC | 3,031,953 | $2,312,000 | 0.13% |
| Alyeska Investment Group, L.P. | 10,000,000 | $7,626,000 | 0.06% |
| BARD ASSOCIATES INC | 87,999 | $67,000 | 0.03% |
| Alyeska Investment Group, L.P. | 4,586,592 | $3,498,000 | 0.03% |
| FRANKLIN STREET ADVISORS INC /NC | 126,000 | $96,000 | 0.02% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,000,000 | $763,000,000 | 0.02% |
| HAMILTON LANE ADVISORS LLC | 23,855 | $18,000 | 0.01% |